NY

Nitin Yadav

Active Director Director DIN 08326905
DIN 08326905 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Nitin Yadav

Data last updated:

Nitin Yadav is a Director at Curevet Pharma Private Limited (since 2019). The company operates in Pharma. Curevet Pharma Private Limited reported revenue of ₹60,239 (FY 2020).

DIN 08326905
Primary Designation Director
Industry Pharma
First Appointment 10 Jan 2019
Oldest Company Age 7 yrs
Largest company Curevet Pharma Private Limited · ₹60,239 (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curevet Pharma Private Limited U24304HR2019PTC077750
Director10 Jan 20192019₹60,239 (FY 2020)Active

Board colleagues of Nitin Yadav

NameDINCompanyDesignation
Nitesh Yadav08690476Curevet Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Curevet Pharma Private Limited
Premium access

Shareholding and investment profile for Nitin Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Yadav

Nitin Yadav currently holds 1 directorship: Curevet Pharma Private Limited (Director, since 10 Jan 2019, revenue ₹60,239 (FY 2020)).

Nitin Yadav was first appointed on 10 Jan 2019 as Director at Curevet Pharma Private Limited.

The current boards of Nitin Yadav's companies include Nitesh Yadav (Curevet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available